Breast cancer (BC) is the second most common cancer among women, comprising 34% of
all cancers, affecting∼ 2.23 million women every year globally. Therefore, early diagnosis of …

Breast cancer (BC) is the most common malignancy responsible for the largest number of
deaths in women worldwide. The risk of develo** BC is predisposed by many factors such …

This comprehensive review paper describes recent advances made in the field of
electrochemical nanobiosensors for the detection of breast cancer (BC) biomarkers such as …

Accumulating evidence suggests that microRNA-326 (miR-326) serves as a tumor
suppressor in the initiation and progression of several human malignancies. However, the …

Stimuli-responsive drug-delivery nanocarriers (DDNs) have been increasingly reported in
the literature as an alternative for breast cancer therapy. Stimuli-responsive DDNs are …

Background: The aim of this work was to investigate if serum and salivary auto-antibodies,
isotypes IgG and IgM, against HER2 and MUC1 tandem repeat fragments could play a role …

The tumor marker CA 15-3 is one of the most import reliable for metastatic breast cancer
monitoring. While it is generally assessed in serum of patients, blood sampling is an …

Background: CEA and CA 15.3 serum tumor markers are currently used in clinical practice
for monitoring therapy. The aim of this study was to evaluate serum level of these markers …

Background and aim SP-D, YKL-40, CCL18 and CA 15–3 are pulmonary markers that have
been extensively investigated in different chronic pulmonary diseases. However, in acute …

Herein, a novel strategy for the construction of a photoelectrochemical aptasensor for tumor
marker mucin 1 (MUC1) was presented, which was based on the effective photoelectron …